Pancreas Allotransplantation for Diabetic Nephropathy and Mild Chronic REnal fAilure Stage Study

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 180 participants.

Also called NCT01067950

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 180 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01067950
Start date
(registry gives no type) (from the registry)
Primary completion
Not reported
Completion
Not reported
Countries
United States, Brazil, Czechia, France, Italy (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01067950. Randomized; no masking; primary purpose treatment. Start 2010-03 (registry gives no type). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Pancreas Allotransplantation for Diabetic Nephropathy and Mild Chronic REnal fAilure Stage Study
Acronym
PANCREAS
Condition
Type 1 Diabetes
Intervention (Procedure)
Isolated Pancreas Transplant
Intervention (Drug)
Intensive Insulin Therapy
Lead sponsor
Nantes University Hospital (class: other)

Record details

Record id
cardio:ct-nct01067950
Content hash
5f0b95713ab446961a27cf6fee63195e1060b9ecf2df5ed028d7f5202989bd84